Industry News

Almac Launches SupplyTraQ™ Technology Solution to Streamline Clinical Trial Supply Administration
Sanofi, GSK, AstraZeneca launch improved flu vaccines
Sanofi, GSK, AstraZeneca launch improved flu vaccines
B. Braun Receives FDA Approval For New Large-Volume Intravenous Containers Only 2 and 3 Liter IV containers approved in the U.S. that are not manufactured with DEHP
J&J says Stelara approved for psoriatic arthritis
Almac Launches SupplyTraQ™ Technology Solution to Streamline Clinical Trial Supply Administration
GHX Signs Two Major Healthcare Providers for New Implantable Device Supply Chain Solution
First in Class Once-Daily Dual Bronchodilator Ultibro® Breezhaler® (QVA149) Approved for the Treatment of COPD in Europe
Landmark TIOSPIR trial demonstrates comparable long-term safety of tiotropium delivered via Respimat® and HandiHaler® in COPD patients Boehringer Ingelheim Pharmaceuticals, Inc.
UPS Survey Finds Global Healthcare Executives Driving Supply Chain Transformation to Reach New Markets
Gentiva® Health Services to Acquire Harden Healthcare - Increases Focus on Dual Eligible Population- Combines Leading Home Health, Hospice and Community Care Providers- Company To Host Call Today at 9:00 a.m. ET
Teva Announces Exclusive Launch of Generic NIASPAN in the United States
GSK signs a multi-year agreement with BARDA to supply the US government with anthrax treatment
Xofigo (radium Ra 223 dichloride) Injection Recommended for Approval in the European Union
Xofigo® (radium Ra 223 dichloride) Injection Recommended for Approval in the European Union
GSK signs a multi-year agreement with BARDA to supply the US government with anthrax treatment
ePharma Launches Mobile Health Solution in Brazil Powered by 3Cinteractive
Dendreon Reports Marketing Authorization for Provenge in EU
Gentiva® Health Services to Acquire Harden Healthcare - Increases Focus on Dual Eligible Population- Combines Leading Home Health, Hospice and Community Care Providers- Company To Host Call Today at 9:00 a.m. ET
Crosstrees Medical Receives FDA 510(k) Clearance for Next Generation Device for Percutaneous Vertebral Augmentation (PVA)
Crosstrees Medical Receives FDA 510(k) Clearance for Next Generation Device for Percutaneous Vertebral Augmentation (PVA)
Gentiva® Health Services to Acquire Harden Healthcare - Increases Focus on Dual Eligible Population- Combines Leading Home Health, Hospice and Community Care Providers- Company To Host Call Today at 9:00 a.m. ET
Naloxone Nasal Spray on Development Fast Track as Emergency Treatment for Opioid Overdose
FDA -Federal judge approves consent decree against Shamrock Medical Solutions Group; Company repeatedly failed to comply with good manufacturing practices
Pennsylvania state legislators debate generic biological medications